肿瘤
词汇介绍
拓展阅读
解析
Percutaneous 英 /,pɜːkjʊ'teɪnɪəs/ 美 /,pɝkju'tenɪəs/
释 义 adj. 经皮的;经由皮肤的
例 句 Objective: TO investigate the nursing and observation of bleeding after percutaneous coronary interventions (PCI), so as to alleviate the painful and treat the complication of bleeding in time. 目的:探讨经皮冠状动脉介入术后出血并发症的观察与护理,以减轻病人的痛苦,减少和及时处理术后出血并发症。
Radiofrequency /,reidiəu-'fri:kwənsi/
释 义 n. 高频,射频;高周波
例 句 Mobile phones are often prohibited in hospitals and on airplanes, as the radiofrequency signals may interfere with certain electro-medical devices and navigation systems. 由于射频信号可能会干扰某些电子医疗装置和导航系统,在医院里和飞机上通常禁止使用移动电话。
Ablation 英 /ə'bleɪʃ(ə)n/ 美 /ə'bleʃən/
释 义 n. [水文] 消融;切除
同根词 ablative adj. 离格的;消融的;ablative n. 烧蚀材料;离格;
例 句 But if these go to plan, fewer procedures like cardiac ablation will need to be repeated, lowering the number of readmissions, and with it cost of treatment. 不过如果一切都按计划进行,那么心脏消融术重复的次数就可以减少,从而降低再次入院的次数和治疗费用。
概述
Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses复制标题
肾部分切除术和经皮消融治疗cT1肾肿块后的肿瘤学结果
发表时间:2019-08-01
影响因子:17.3
作者: Jack R. Andrews
期刊:Eur. Urol.
Following Institutional Review Board approval, we identified patients treated with PN, percutaneous radiofrequency ablation (RFA), or percutaneous cryoablation at our institution for sporadic, localized (N0M0), cT1 solid renal mass between 2000 and 2011, as published in 2015. The cT1 renal masses were defined as renal masses ≤7 cm identified on imaging as per the 2016 AJCC cancer staging manual. All renal masses with radiographic evidence of extension beyond the kidney or extension into the renal or segmental veins were excluded from analysis, as were patients with a history of prior RCC or genetic syndromes. A total of 1422 patients were treated with PN (N = 1055), RFA (N = 180), or cryoablation (N = 187) for cT1aN0M0 renal masses, and 376 patients were treated with PN (N = 324) or cryoablation (N = 52) for cT1bN0M0 renal masses. Since the previous analysis, four patients (three PN and one cryoablation) were excluded because of research authorization refusals and one patient was excluded due to previously unrecorded M1 disease at PN. Patient surveillance was generally recommended at 3, 6, 12, 18, and 24 mo, followed by yearly intervals; variance from this protocol was based on pathologic features and clinical health status.
译文